Search results

• Chloroquine
  ...ificant therapeutic value as an anti-malarial drug. It was introduced into clinical practice in 1947 for the prophylactic treatment of malaria.<ref>http://www. * Chloroquine is in clinical trials as an investigational [[antiretroviral]] in humans with [[AIDS|HIV-1/AIDS]]
  16 KB (2,187 words) - 16:41, 27 September 2010
• Chlorphenamine
  ...l Hypotheses'', 2006; 66(4), 689 - 690. </ref> However, extensive clinical trials of its psychiatric properties in humans have not been conducted. It inhibit
  6 KB (745 words) - 15:05, 6 July 2010
• Dexamethasone
  ...erative removal of impacted third molar teeth |journal=European Journal of Clinical Pharmacology |volume=44 |issue=3 |pages=275–277 |year=2004 |pmid= 8491244 ...ino T, Ichijo T, Chrousos GP |title=Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder
  18 KB (2,498 words) - 16:41, 27 September 2010
• Acetylcysteine
  ==Clinical use== ...'' |title=N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up |journal=Am. Heart J. |volume=148 |issue=
  28 KB (3,682 words) - 16:42, 27 September 2010
• Naloxone
  <!--Clinical data--> ...].<ref>{{cite book|last1=Roberts|first1=James R.|title=Roberts and Hedges' clinical procedures in emergency medicine|date=2014|publisher=Elsevier Health Scienc
  33 KB (4,541 words) - 10:57, 17 June 2016
• Carbamazepine
  ...reatment of bipolar disorder: a systematic review of randomized controlled trials |journal=Hum Psychopharmacol |volume=24 |issue=1 |pages=19–28 |year=2009 ...on of therapy.<ref>{{cite book|last=Bauer |first=Larry A. |title=[[Applied Clinical Pharmacokinetics]] |edition=2^nd |year=2008 |publisher=[[McGraw-H
  16 KB (2,164 words) - 16:42, 27 September 2010
• Levamisole
  ==Clinical use== ...racil]] to treat [[colon cancer]]. There is no good evidence from clinical trials that its addition to fluorouracil therapy benefits patients with colon canc
  10 KB (1,350 words) - 16:42, 27 September 2010
• Praziquantel
  ...tel in the Treatment of Neurocysticercosis: A Meta-analysis of Comparative Trials |journal=PLoS Negl Trop Dis |volume=2 |issue=3 |pages=e194 |year=2008 |pmid ...l.<ref>{{cite journal |author=Quinn DI, Day RO |title=Drug interactions of clinical importance. An updated guide |journal=Drug Saf |volume=12 |issue=6 |pages=3
  12 KB (1,580 words) - 16:42, 27 September 2010
• Clindamycin
  ...oi=10.1016/S0190-9622(97)70177-4}}</ref> A [[blind experiment#Single-blind trials|single-blind]] study comparing this combination to [[adapalene]], a [[retin ...oot, Richard E.; Francis Waldvogel, Lawrence Corey, Walter E. Stamm |title=Clinical infectious diseases: a practical approach |publisher=Oxford University Pres
  25 KB (3,261 words) - 14:17, 11 September 2010
• Doxycycline
  ...ff A, Massung RF, Christensson B |title=Human granulocytic ehrlichiosis--a clinical case in Scandinavia |journal=Scand. J. Infect. Dis. |volume=33 |issue=1 |pa Field trials in 2005 showed that Doxycycline almost completely eliminates the release of
  20 KB (2,578 words) - 16:43, 27 September 2010
• Vancomycin
  #Early trials used early impure forms of vancomycin ("Mississippi mud"), which were found ==Clinical use==
  31 KB (4,198 words) - 16:43, 27 September 2010
• Clofazimine
  ...olerate the effects of [[Dapsone]] for Tuberculosis.<ref name="ReferenceA">Clinical Microbiology Made Ridiculously Simple</ref> ...r named Chang identified its effectiveness against leprosy. After clinical trials in Nigeria and elsewhere during the 1960s, some sponsored by the Swiss phar
  12 KB (1,651 words) - 16:43, 27 September 2010
• Dapsone
  ...wn recluse]] spider bites, dapsone is often used effectively, but clinical trials do not demonstrate similar effectiveness<ref>Elston DM, Miller SD, Young RJ
  15 KB (2,087 words) - 16:43, 27 September 2010
• Streptomycin
  ...scientific approach: from alternation to randomised allocation in clinical trials in the 1940s | journal = [[British Medical Journal]] (Clinical Research Ed.)
  9 KB (1,069 words) - 15:06, 6 July 2010
• Amphotericin B
  ...d Richard T. liposomal formulation, structure, mechanism of action and pre-clinical experience. Journal of Antimicrobial Chemotherapy (2002) 49, 21-30</ref> Th ==Clinical efficacy==
  13 KB (1,785 words) - 16:44, 27 September 2010
• Didanosine
  ...ld inhibit HIV replication in the test tube and conducted initial clinical trials showing that didanosine had activity in patients infected with HIV. On beha ...pheral [[neuropathy]] occurred in 21-26% of participants in key didanosine trials.<ref name="Videxpi" />
  9 KB (1,239 words) - 16:44, 27 September 2010
• Emtricitabine
  ...e analyses of plasma HIV RNA levels and CD4 cell counts in two Phase III [[clinical trial]]s of Emtriva of 48 weeks duration. ...symptoms are generally mild to moderate in severity, but they caused 1% of clinical trial patients to give up treatment. Skin discoloration, which is typically
  5 KB (667 words) - 16:44, 27 September 2010
• Nevirapine
  ...|author= Patel SS, Benfield P |title=New drug profile: nevirapine |journal=Clinical Immunotherapeutics |volume=6|issue=4|pages=307–317 |year=1996 |month=Oct ==Clinical efficacy==
  15 KB (2,090 words) - 16:45, 27 September 2010
• Lopinavir
  ...with lopinavir/ritonavir are [[diarrhea]] and [[nausea]]. In key clinical trials, moderate or severe diarrhea occurred in up to 27% of patients, and moderat
  8 KB (1,109 words) - 16:45, 27 September 2010
• Ritonavir
  ...lowing the clinician to lower their dose and frequency and improving their clinical efficacy. ...tt Labs. Most of the $200,000,000 figure cited by Abbott paid for clinical trials-despite NIH offering to pay for them-because Abbott was concerned about "pu
  9 KB (1,233 words) - 15:07, 6 July 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)